Erythromycin Panpharma

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Erythromycin lactobionate 1.49 g equivalent to 1 g erythromycin;  

Commercializzato da:

Multichem NZ Limited

Dosaggio:

1 g

Forma farmaceutica:

Powder for infusion

Composizione:

Active: Erythromycin lactobionate 1.49 g equivalent to 1 g erythromycin  

Tipo di ricetta:

Prescription

Indicazioni terapeutiche:

Upper respiratory tract infections caused by Streptococcus pyogenes (Group A beta haemolytic streptococci); Lower respiratory tract infections caused by Streptococcus pyogenes (Group A betahaemolytic streptococci); Skin and skin structure infections caused by Streptococcus pyogenes.

Dettagli prodotto:

Package - Contents - Shelf Life: Vial, glass, 20 mL glass vial type III, in a cardboard carton - 1 dose units - 3 years from date of manufacture stored at or below 30°C protect from light - Vial, glass, 20 mL glass vial type III, in a cardboard carton - 10 dose units - 3 years from date of manufacture stored at or below 30°C protect from light - Vial, glass, 20 mL glass vial type III, in a cardboard carton - 25 dose units - 3 years from date of manufacture stored at or below 30°C protect from light

Data dell'autorizzazione:

2017-08-14